ATE75395T1 - Linolensaeuren enthaltende pharmazeutische und diaet-zusammensetzungen zur behandlung von gutartiger prostatahypertrophie. - Google Patents

Linolensaeuren enthaltende pharmazeutische und diaet-zusammensetzungen zur behandlung von gutartiger prostatahypertrophie.

Info

Publication number: ATE75395T1
Authority: AT; Austria
Prior art keywords: treatment; pharmaceutical; compositions containing; benign prostate; prostate hypertrophy
Prior art date: 1985-03-08

Application number

AT86301300T

Other languages

English (en)

Inventor

David Frederick C O E Horrobin

Meadows Woodbridge

Original Assignee

Efamol Holdings

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-03-08

Filing date

1986-02-24

Publication date

1992-05-15

1986-02-24 Application filed by Efamol Holdings filed Critical Efamol Holdings

1992-05-15 Application granted granted Critical

1992-05-15 Publication of ATE75395T1 publication Critical patent/ATE75395T1/de

Links

239000000203 mixture Substances 0.000 title abstract 2
206010020880 Hypertrophy Diseases 0.000 title 1
239000002253 acid Substances 0.000 title 1
150000007513 acids Chemical class 0.000 title 1
235000005911 diet Nutrition 0.000 title 1
230000000378 dietary effect Effects 0.000 title 1
210000002307 prostate Anatomy 0.000 title 1
HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 abstract 1
206010004446 Benign prostatic hyperplasia Diseases 0.000 abstract 1
235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 abstract 1
208000004403 Prostatic Hyperplasia Diseases 0.000 abstract 1
HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 abstract 1
239000003085 diluting agent Substances 0.000 abstract 1
VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 abstract 1
235000020664 gamma-linolenic acid Nutrition 0.000 abstract 1
VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 abstract 1
229960002733 gamolenic acid Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)

AT86301300T 1985-03-08 1986-02-24 Linolensaeuren enthaltende pharmazeutische und diaet-zusammensetzungen zur behandlung von gutartiger prostatahypertrophie. ATE75395T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB858506027A GB8506027D0 (en)	1985-03-08	1985-03-08	Pharmaceutical & dietary compositions
EP86301300A EP0201159B1 (de)	1985-03-08	1986-02-24	Linolensäuren enthaltende pharmazeutische und Diät-Zusammensetzungen zur Behandlung von gutartiger Prostatahypertrophie

Publications (1)

Publication Number	Publication Date
ATE75395T1 true ATE75395T1 (de)	1992-05-15

Family

ID=10575663

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT86301300T ATE75395T1 (de)	1985-03-08	1986-02-24	Linolensaeuren enthaltende pharmazeutische und diaet-zusammensetzungen zur behandlung von gutartiger prostatahypertrophie.

Country Status (11)

Country	Link
US (1)	US4898885A (de)
EP (1)	EP0201159B1 (de)
JP (1)	JPH0717515B2 (de)
AT (1)	ATE75395T1 (de)
AU (1)	AU581295B2 (de)
CA (1)	CA1268122A (de)
DE (1)	DE3685052D1 (de)
GB (1)	GB8506027D0 (de)
HK (1)	HK8294A (de)
IE (1)	IE58891B1 (de)
ZA (1)	ZA861459B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2716739B2 (ja) *	1988-07-26	1998-02-18	インデナエス．ピー．エイ	血管運動作用を有する化粧用組成物
EP0437694B1 (de) *	1990-01-16	1993-06-16	Boots Pharma GmbH	Verwendung einer Hydroxyoctadecadiensäure, deren zur Ketoform oxidierte Säure sowie deren Derivate zur Therapie östrogenabhängiger Krankheiten, sowie pharmazeutische Zusammensetzungen, die diese enthalten
GB9012651D0 (en) *	1990-06-06	1990-07-25	Efamol Holdings	Essential fatty acid treatment
ES2136189T3 (es) *	1993-01-15	1999-11-16	Abbott Lab	Lipidos estructurados.
AU711482B2 (en) *	1994-06-28	1999-10-14	Scotia Holdings Plc	Compositions for treatment of diabetic complications
DE19825591A1 (de) *	1998-06-09	1999-12-23	Jenapharm Gmbh	Pharmazeutische Kombinationen zum Ausgleich eines Testosteron-Defizits beim Mann mit gleichzeitigem Schutz der Prostata
DE10006836B4 (de) *	2000-04-18	2005-03-24	Bitec Gmbh	Verwendung von Omega-3-Fettsäuren und/oder Verbindungen von Omega-3-Fettsäuren
CA2436650A1 (en) *	2003-08-06	2005-02-06	Naturia Inc.	Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
IT1391663B1 (it)	2008-11-10	2012-01-17	Giuliani Spa	Uso di composti atti ad inibire l' attivita' dell'enzima 5alfa-reduttasi e composizioni farmaceutiche e cosmetiche che li contengono
GB0907413D0 (en)	2009-04-29	2009-06-10	Equateq Ltd	Novel methods
ES2385240B1 (es)	2010-07-26	2013-09-23	Gp-Pharm, S.A.	Cápsulas de principios activos farmacéuticos y ácidos grasos poliinsaturados para el tratamiento de enfermedades de la próstata.
US8293790B2 (en)	2011-10-19	2012-10-23	Dignity Sciences Limited	Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
MX375328B (es)	2014-06-04	2025-03-06	Ds Biopharma Ltd	Composiciones farmacéuticas que comprenden ácido dihomo-gamma-linolénico (dgla) y uso de las mismas
US20210315851A1 (en)	2020-04-03	2021-10-14	Afimmune Limited	Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4273763A (en) *	1978-01-23	1981-06-16	Efamol Limited	Pharmaceutical and dietary compositions
EP0004770B1 (de) *	1978-04-11	1984-06-13	Efamol Limited	Pharmazeutische und diätetische Zusammensetzung mit Gehalt an Gamma-Linolensäuren
IE49783B1 (en) *	1979-05-18	1985-12-11	Efamol Ltd	Pharmaceutical and dietary composition comprising epsilon-linolenic acids
IE53332B1 (en) *	1980-03-14	1988-10-26	Efamol Ltd	Pharmaceutical compositions
US4386072A (en) *	1981-06-26	1983-05-31	Horrobin David F	Treatment of disorders of inflammation and immunity and disorders associated with smooth muscle spasm and compositions therefor
ATE11014T1 (de) *	1981-07-14	1985-01-15	Efamol Limited	Pharmazeutische und diaetetische zusammensetzung zur erhoehung der serie-l-pg-produktion.
GB8302708D0 (en) *	1983-02-01	1983-03-02	Efamol Ltd	Pharmaceutical and dietary composition

1985
- 1985-03-08 GB GB858506027A patent/GB8506027D0/en active Pending
1986
- 1986-02-24 AT AT86301300T patent/ATE75395T1/de active
- 1986-02-24 DE DE8686301300T patent/DE3685052D1/de not_active Expired - Fee Related
- 1986-02-24 EP EP86301300A patent/EP0201159B1/de not_active Expired - Lifetime
- 1986-02-26 IE IE51686A patent/IE58891B1/en not_active IP Right Cessation
- 1986-02-27 ZA ZA861459A patent/ZA861459B/xx unknown
- 1986-03-03 CA CA000503141A patent/CA1268122A/en not_active Expired - Fee Related
- 1986-03-05 AU AU54285/86A patent/AU581295B2/en not_active Ceased
- 1986-03-06 JP JP61047468A patent/JPH0717515B2/ja not_active Expired - Lifetime
1988
- 1988-08-15 US US07/232,515 patent/US4898885A/en not_active Expired - Fee Related
1994
- 1994-01-21 HK HK82/94A patent/HK8294A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
HK8294A (en)	1994-02-04
JPH0717515B2 (ja)	1995-03-01
JPS61207330A (ja)	1986-09-13
AU581295B2 (en)	1989-02-16
ZA861459B (en)	1986-11-26
EP0201159A3 (en)	1989-08-09
AU5428586A (en)	1986-09-11
DE3685052D1 (de)	1992-06-04
EP0201159A2 (de)	1986-11-12
IE860516L (en)	1986-09-08
US4898885A (en)	1990-02-06
GB8506027D0 (en)	1985-04-11
IE58891B1 (en)	1993-12-01
EP0201159B1 (de)	1992-04-29
CA1268122A (en)	1990-04-24

Similar Documents

Publication	Publication Date	Title
MY101791A (en)	1992-01-31	New benzimidazole derivatives
NO940277L (no)	1994-07-28	Triglycerider og blandinger av slike
PL268927A1 (en)	1989-01-23	Method of obtaining novel derivatives of benzimidazole
IS1904B (is)	2003-11-20	Hliðstæðar aðferðir við framleiðslu á nýjum (R)-5-karbamóýl-8-flúor-3-N,N-tvíútskiptum-amínó-3,4-díhýdró-2H-1-bensópýrönum
PT82841A (en)	1986-07-01	Process for the preparation of novel amino acid derivatives and of pharmaceutical compositions containing the same
DE3685052D1 (de)	1992-06-04	Linolensaeuren enthaltende pharmazeutische und diaet-zusammensetzungen zur behandlung von gutartiger prostatahypertrophie.
ES8402262A1 (es)	1984-01-16	Procedimiento para la obtencion de nuevos derivados de omega-ciano-1,omega-difenil-aza-alcano.
GR3025742T3 (en)	1998-03-31	New pyrazine derivatives, their preparation and their use.
AU554413B2 (en)	1986-08-21	Linoleic acid and essential fatty acid compositions as
ES483661A1 (es)	1980-04-16	Procedimiento para la obtencion de derivados de 1,4-dihidro-piridina sila-sustituidos
DE3577317D1 (de)	1990-05-31	Oxa-fenchole und oxa-fenchylamine, geeignet zur herstellung hochwirksamer suessstoffe.
GR3002215T3 (en)	1992-12-30	Calcium lactate-glycerine additive, process for its preparation and its use
ATE2746T1 (de)	1983-03-15	Piperidinderivate von 4,5-dialkyl-3-hydroxypyrrol-2-carbons[ureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE67479T1 (de)	1991-10-15	Ester von salsalat mit guajakol zur behandlung von phlogistischen bronchopneumopathien.
ATE4808T1 (de)	1983-10-15	Piperidinderivate von 3-hydroxy-thiophen-2carbons[ureestern,ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
JPS5217482A (en)	1977-02-09	Preparation of quinazolinone derivatives
JPS52130905A (en)	1977-11-02	Medicinal composition
ES8608861A1 (es)	1986-09-01	Procedimiento para la preparacion de composiciones farmaceuticas hidrosolubles a base de sales de fosfomicina.
JPS5251362A (en)	1977-04-25	Preparation of optically active pyrrolidine derivatives
JPS51151383A (en)	1976-12-25	Process for cultivating excrement- deodorizing bacteria
GB2006207A (en)	1979-05-02	N- epsilon -Trimethyl-L-lysine salts
JPS5285200A (en)	1977-07-15	Preparation of amino acid
AU102478S (en)	1989-01-05	Flag
BG52067B2 (en)	1996-04-30	Antihypoxic and brain-protection antidote composition
ATE88342T1 (de)	1993-05-15	Pharmazeutische zubereitungen zur behandlung der psoriasis, psoriatischen arthritis, neurodermitis und enteritis regionalis crohn.